- $2.81bn
- $2.15bn
- $110.32m
- 63
- 23
- 96
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 110 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 18 | 32.1 | 65 | 191 | 200 |
Operating Profit | -18 | -32.1 | -65 | -191 | -89.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18 | -32.1 | -65 | -189 | -70 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18 | -32.1 | -65 | -189 | -70.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -18 | -32.1 | -65 | -189 | -70.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18 | -32.1 | -65 | -189 | -70.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.517 | -0.923 | -1.87 | -5.19 | -1.47 |
Dividends per Share |